FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Ranbaxy Lac-Hydrin Recall

Lac-Hydrin (ammonium lactate) Cream, 12%, packaged in a) 280 g (2 x 140 g tubes)

Ranbaxy Inc. · Princeton, NJ

Risk level
Class III
Reported by FDA
Feb 20, 2013
Recall ID
D-163-2013
Check your lot numberHow we source this data

Summary

Ranbaxy recalled Lac-Hydrin starting Dec 27, 2012. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-163-2013 on Feb 20, 2013. Reason: Crystallization: Recall is due to a non-characteristic gritty/sandy texture to the product which is likely due to some crystallization of the product. Status: Terminated.

Why it was recalled

Crystallization: Recall is due to a non-characteristic gritty/sandy texture to the product which is likely due to some crystallization of the product.

Product description

Lac-Hydrin (ammonium lactate) Cream, 12%, packaged in a) 280 g (2 x 140 g tubes), NDC 10631-099-28; b) 385 g bottle, NDC 10631-099-38; Rx only, Ranbaxy, Jacksonville, FL 32257 USA.

Lot numbers, UPCs & expiration codes

Lot #: RB91881, Exp 07/14; RB91891, Exp 07/13

Where it was sold

Nationwide and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-163-2013
Classification
Class III
Status
Terminated
Recall initiated
Dec 27, 2012
FDA report date
Feb 20, 2013
Quantity
6,535 tubes and bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Ranbaxy Inc.

Original FDA data

Every field from FDA enforcement report D-163-2013, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Terminated
Country
United States
Event ID
64286
Address
600 College Rd E Ste 2100
Code information
Lot #: RB91881, Exp 07/14; RB91891, Exp 07/13
Postal code
08540-6636
Report date
Feb 20, 2013
Product type
Drugs
Recall number
D-163-2013
Classification
Class III
Recalling firm
Ranbaxy Inc.
Product quantity
6,535 tubes and bottles
Termination date
Apr 9, 2014
Reason for recall
Crystallization: Recall is due to a non-characteristic gritty/sandy texture to the product which is likely due to some crystallization of the product.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Lac-Hydrin (ammonium lactate) Cream, 12%, packaged in a) 280 g (2 x 140 g tubes), NDC 10631-099-28; b) 385 g bottle, NDC 10631-099-38; Rx only, Ranbaxy, Jacksonville, FL 32257 USA.
Distribution pattern
Nationwide and Puerto Rico
Recall initiation date
Dec 27, 2012
Initial firm notification
Letter
Center classification date
Feb 12, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-163-2013, published Feb 20, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls